BSX R&D Expenses

Boston Scientific · R&D Expenses

BSX logo

BSX R&D Expenses

Latest reported$2.15B
BSX TTM R&D Expenses ($0.00 → $2.15B)
High-resolution chart · PNG

BSX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
2,153,000,000
2,125,000,000
2,052,000,000
1,943,000,000
1,836,000,000
1,693,000,000
1,616,000,000
1,519,000,000
1,468,000,000
1,444,000,000
1,415,000,000
1,382,000,000
1,365,000,000
1,341,000,000
1,323,000,000
1,313,000,000
1,284,000,000
1,247,000,000
1,204,000,000
1,170,000,000
1,175,000,000
1,119,000,000
1,143,000,000
1,166,000,000
1,157,000,000
1,195,000,000
1,175,000,000
1,154,000,000
1,137,000,000
1,132,000,000
1,113,000,000
1,089,000,000
1,054,000,000
1,023,000,000
997,000,000
989,000,000
967,000,000
945,000,000
920,000,000
908,000,000
897,000,000
895,000,000
877,000,000
841,000,000
832,000,000
818,000,000
817,000,000
825,000,000
830,000,000
847,000,000
860,000,000
883,000,000
886,000,000
876,000,000
887,000,000
878,000,000
887,000,000
897,000,000
894,000,000
889,000,000
890,000,000
899,000,000
940,000,000
956,000,000
984,000,000
1,015,000,000
1,019,000,000
1,035,000,000
1,029,000,000
1,019,000,000
1,006,000,000
1,005,000,000
1,024,000,000
1,046,000,000
1,096,000,000
1,107,000,000
1,108,000,000
1,116,000,000
1,008,000,000
915,000,000
824,000,000
707,000,000
680,000,000
664,000,000
628,000,000
594,000,000
569,000,000
539,000,000
507,000,000
483,000,000
452,000,000
419,000,000
393,000,000
370,000,000
343,000,000
47,000,000
42,000,000
28,000,000
8,000,000
262,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.